Goldan Keith A. 4
4 · Syndax Pharmaceuticals Inc · Filed May 19, 2025
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-05-19+3,000→ 93,746 total
Footnotes (1)
- [F1]The purchase prices ranged from $8.8465 to $9.2825.